"Triple Marker" for ectopic pregnancy [1] (multiple letters)

Fertility and Sterility

Volumn 82, Issue 4, 2004, Pages 986-987

  Ferrero, Simone ^a   Anserini, Paola ^a   Remorgida, Valentino ^a   Ragni, Nicola ^a   Mueller, Michael D ^b   Bersinger, Nick A ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN; PROTEIN A; SPHINGOLIPID ACTIVATOR PROTEIN 2; VASCULOTROPIN;

BLOOD CELL; BLOOD CLOTTING; BLOOD SAMPLING; CELL GRANULE; CENTRIFUGATION; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DEGRANULATION; DIAGNOSTIC PROCEDURE; DISEASE MARKER; ECTOPIC PREGNANCY; IN VITRO STUDY; LETTER; MECHANICAL STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; ROOM TEMPERATURE; SERUM; STANDARDIZATION; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; TIME; VEIN PUNCTURE;

EID: 5144222379     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2004.07.002     Document Type: Letter

References (5)

1. M.D. Mueller L. Raio S. Spoerri F. Ghezzi E. Dreher N.A. Bersinger Novel placental and nonplacental serum markers in ectopic versus normal intrauterine pregnancy Fertil Steril 81 2004 1106 1111
2. K. Werther I.J. Christensen H.J. Nielsen Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets Scand J Invest 62 2002 343 350
3. E. Hormbrey P. Gillespie K. Turner C. Han A. Roberts D. McGrouther A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood is the current literature meaningful? Clin Exp Metastasis 19 2002 651 663
4. E. Gunsilius A. Petzer G. Stockhammer W. Nussbaumer P. Schumacher J. Clausen Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood Oncology 58 2000 169 174
5. W. Wynendaele R. Derua M.F. Hoylaerts A. Pawinski E. Waelkens E.A. de Bruijn Vascular endothelial growth factor measured in platelet poor plasma allows optimal separatïon between cancer patients and volunteers a key to study an angiogenic marker in vivo? Ann Oncol 10 1999 965 971